Hanoi (VNA) - MEDIAIPLUS will showcase its innovative platforms MediC and FiCRO at MWC 2025, held from March 3 to 6 at Hall 7, Stand 7F62, Fira Gran Via, in Barcelona, Spain.
These solutions are designed to eliminate inefficiencies in trial preparation, reducing both time and cost by over 80% compared to traditional manual processes.
MEDIAIPLUS revolutionises global clinical trials with AI-driven solutions.
In addition, by leveraging AI and 5G technologies in collaboration with global telecommunications companies, MEDIAIPLUS aims to enhance patient participation and improve access to clinical trials. Utilizing high-speed, low-latency 5G networks to enable real-time remote monitoring, telemedicine consultation, MEDIAIPLUS is exploring the feasibility of scalable remote clinical trial models, ensuring that clinical research becomes more accessible, efficient, and globally connected.
AI-Driven Innovation in Clinical Trials
MEDIAIPLUS is transforming clinical research by leveraging AI to streamline traditionally manual and repetitive trial preparation processes. The company’s two core platforms provide advanced capabilities:
- MediC – A real-time clinical trial data platform offering access to over 710,000 global clinical trial datasets, making it an essential tool for drug and medical device development.
- FiCRO – A data-driven CRO-matching platform that connects sponsors with the most suitable Contract Research Organizations (CROs), ensuring optimal clinical trials.
MediC: Tailored Clinical Trial Data Reports
MediC integrates data from over 710,000 clinical trials worldwide, surpassing even NIH datasets in scale. The data includes not only clinical trial information but also patents, research papers, the latest regulations, and guidelines, encompassing all the essential information needed for clinical trial design. The platform refines raw data through natural language processing and annotation, transforming it into actionable insights via AI technology.
This service addresses challenges faced by early-stage pharmaceutical and biotech companies during drug development, offering solutions like competitive drug analysis, regulatory insights, and clinical trial report generation to facilitate fast and efficient decision-making.
MediC allows researchers to streamline the traditionally complex process of analyzing over 1,300 pages of clinical trial data, enabling faster trial design. Additionally, the platform visualizes competitive drug and trial information, empowering researchers to develop more precise strategies.
MediC has solidified its position as a business intelligence solution that revolutionizes decision-making in clinical trials, enhancing preparation and design phases through data-driven innovation.
FiCRO: A Global Data Hub for Clinical Trials
FiCRO is a data-driven matching platform that connects sponsors in drug development, medical devices, and biotech with CROs(Contract Research Organization). By leveraging digital RFPs, historical CRO performance data, and areas of expertise, FiCRO significantly boosts the success rate of clinical trials, while supporting online quote issuance.
Traditionally, the contracting process between sponsors and CROs relied heavily on time-consuming methods like phone calls and emails. FiCRO streamlines this process with transparent, data-backed information sharing, preventing overestimated costs and enabling cost-effective matches.
During beta testing, a Korean biotech company reduced its CRO selection process from three months to five days, while a UK-based biotech company shortened its process from five months to 12 days. On average, FiCRO reduced CRO search durations by 75.25 days, cutting time and costs by 91%.
Through FiCRO, each company is expanding competitive services to efficiently launch biotech and medical products beyond its domestic markets into the global market. MEDIAIPLUS is also planning to introduce new services, including researcher matching and regulatory prediction and optimization, further lowering barriers to global clinical trials. Through FiCRO, MEDIAIPLUS is transforming clinical trial preparation processes with data-driven CRO matching, solidifying its role as a pivotal hub in the global clinical trial ecosystem./.
